Institutional members access full text with Ovid®

Share this article on:

Linezolid Use in Hospitalized Children

Hersh, Adam L. MD, PhD*; Lee, Brian R. PhD, MPH; Hedican, Erin B. MPH; Herigon, Josh C. MPH; Newland, Jason G. MD

The Pediatric Infectious Disease Journal: January 2014 - Volume 33 - Issue 1 - p e14–e18
doi: 10.1097/INF.0000000000000011
Antimicrobial Reviews

We used the Pediatric Health Information System to evaluate linezolid use among hospitalized children. From 2003 to 2007, use increased 5-fold, including wide interhospital variation, then stabilized through 2011. Linezolid was responsible for 3% of total antibiotic expenditures. Children with respiratory, oncologic or transplant conditions were the most frequently treated with linezolid.

From the *Pediatric Infectious Diseases, University of Utah, Salt Lake City, UT and Children’s Mercy Hospital and Clinics, Kansas City, MO.

Accepted for Publication August 19, 2013.

The authors have no funding or conflicts of interest to disclose.

Address for Correspondence: Adam L. Hersh, MD, PhD, 295 Chipeta Way, Salt Lake City, UT 84108. E-mail:

© 2014 by Lippincott Williams & Wilkins, Inc.